Your browser doesn't support javascript.
loading
Acalabrutinib and its use in the treatment of chronic lymphocytic leukemia.
Egyed, Miklos; Lueff, Sandor; Borbely, Judit; Illes, Arpad.
Affiliation
  • Egyed M; Department of Hematology, Somogy County Moritz Kaposi General Hospital, Kaposvar, Hungary.
  • Lueff S; Department of Hematology, Somogy County Moritz Kaposi General Hospital, Kaposvar, Hungary.
  • Borbely J; AstraZeneca, Budapest, 1116, Hungary.
  • Illes A; Department of Internal Medicine, University of Debrecen, Debrecen, Hungary.
Future Oncol ; 18(7): 755-769, 2022 Mar.
Article in En | MEDLINE | ID: mdl-35139644
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Benzamides / Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Agents Limits: Humans Language: En Journal: Future Oncol Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Benzamides / Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Agents Limits: Humans Language: En Journal: Future Oncol Year: 2022 Document type: Article Affiliation country: